Experienced in Subvalvular Aortic Stenosis

Won-jang M. Kim

Songnam, KR 
Clinical Trials:Currently Recruiting for 2 Trials
Experienced in Subvalvular Aortic Stenosis
Songnam, KR 
OverviewLocationsClinical Research

Overview

Won-jang Kim practices in Songnam, Republic of Korea. Kim is rated as an Experienced expert by MediFind in the treatment of Subvalvular Aortic Stenosis. Their top areas of expertise are Coronary Heart Disease, Unstable Angina, Angina, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Their clinical research consists of co-authoring 89 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Subvalvular Aortic Stenosis.

Locations

Songnam, Republic of Korea
Other Locations
Goyang, Republic of Korea
Republic of Korea
Gyeonggi-do, Republic of Korea
Yeouido St. Mary's Hospital, St. Vincent's Hospital, Suwon, Republic of Korea
Seoul, 138736, Republic of Korea
Gwangju, 501757, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Recruiting
Publish Date: December 27, 2024
Intervention Type: Procedure
Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Recruiting
Publish Date: December 12, 2024
Intervention Type: Device
Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of BIOFREEDOM™ FAMILY Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Terminated
Publish Date: September 30, 2025
Intervention Type: Device
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: June 06, 2025
Intervention Type: Drug
Study Drugs: Tailored antithrombotic strategy, Conventional antithrombotic strategy
Study Phase: Phase 4
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Drug
Study Phase: Phase 4
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Terminated
Publish Date: December 20, 2023
Intervention Type: Device
Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2023
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Device, Drug
Study Drug: Optimal Medical treatment
Study Phase: Phase 4
A Prospective, Open Label, Multi-center, Dual Arm, Randomized Trial : The ROTA-ISR (Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis) Trial
A Prospective, Open Label, Multi-center, Dual Arm, Randomized Trial : The ROTA-ISR (Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis) Trial
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
a Multi-center, Open-label, Nationwide Registry-based, Randomized, Pragmatic Trial Comparing 2 Post-PCI Management Strategies in High-risk PCI Patients With Complex Clinical and Lesion Characteristics
a Multi-center, Open-label, Nationwide Registry-based, Randomized, Pragmatic Trial Comparing 2 Post-PCI Management Strategies in High-risk PCI Patients With Complex Clinical and Lesion Characteristics
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
a Multicenter, Randomized, Open-label, Active-treatment, Controlled Trial to Compare the Efficacy of NOAC With Edoxaban vs. Dual Antiplatelet Therapy (DAPT) for Prevention of Leaflet Thrombosis (Documented by Cardiac CT Imaging) and Cerebral Embolization (Documented With Brain DW-MRI Imaging) in Patients Without an Absolute Indication for Chronic OAC After Successful TAVR
a Multicenter, Randomized, Open-label, Active-treatment, Controlled Trial to Compare the Efficacy of NOAC With Edoxaban vs. Dual Antiplatelet Therapy (DAPT) for Prevention of Leaflet Thrombosis (Documented by Cardiac CT Imaging) and Cerebral Embolization (Documented With Brain DW-MRI Imaging) in Patients Without an Absolute Indication for Chronic OAC After Successful TAVR
Enrollment Status: Completed
Publish Date: November 08, 2021
Intervention Type: Drug
Study Drugs: NOAC, DAPT
Study Phase: Phase 4
View 9 Less Clinical Trials

89 Total Publications

Role of routine surveillance stress testing in patients with or without imaging-guided or physiology-guided PCI.
Role of routine surveillance stress testing in patients with or without imaging-guided or physiology-guided PCI.
Journal: Heart (British Cardiac Society)
Published: May 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kim's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile